Trials / Unknown
UnknownNCT02288754
Detection of Tumor DNA in Blood Samples From Cancer Patients
Detection of Tumor DNA in Blood Samples From Patients With Late Stage Cancer and "Healthy Controls"
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- Lexent Bio, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The aim of this study is to employ genomic detection methodologies to measure the relative amount of tumor nucleic acids in the blood of a cancer patient with diagnosed metastatic disease that is either commencing, currently undergoing or completed cytotoxic chemotherapy treatment. More generally, this approach will allow us to develop a quantitative measure of therapy efficacy via the counting of the relative changes in tumor molecules over the course of treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | Blood test | No intervention except to collect blood for diagnostic test development |
Timeline
- Start date
- 2014-12-01
- Primary completion
- 2019-11-01
- Completion
- 2020-11-01
- First posted
- 2014-11-11
- Last updated
- 2019-08-14
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02288754. Inclusion in this directory is not an endorsement.